Are Platinum Drugs Ineffective for Triple-Negative Breast Cancer With Residual Invasive Disease After Neoadjuvant Chemotherapy?

J Clin Oncol. 2021 Nov 1;39(31):3521-3522. doi: 10.1200/JCO.21.01757. Epub 2021 Sep 23.

¹ Yumiko Shimanuki, RPh, Department of Pharmacy, National Center for Global Health and Medicine, Tokyo, Japan; Akihiko Shimomura, MD, PhD, Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan; Kenichi Yoshimura, PhD, Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, Japan; Hiroyuki Terakado, RPh, Department of Pharmacy, National Center for Global Health and Medicine, Tokyo, Japan; and Chikako Shimizu, MD, PhD, Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.

No abstract available

Publication types